Lattice Semiconductor Corporation (NASDAQ:LSCC) shares increased 0.37% in last trading session and ended the day at $5.37. LSCC Gross Margin is 54.20% and its has a return on assets of -19.10%. Lattice Semiconductor Corporation (NASDAQ:LSCC) quarterly performance is -7.73%.
Lattice Semiconductor Corporation (NASDAQ:LSCC) is expected to announce first quarter financial results estimated on 04/14/2016.
Twitter Inc (NYSE:TWTR) ended the last trading day at $16.65. Company weekly volatility is calculated as 5.68% and price to cash ratio as 3.44. Twitter Inc (NYSE:TWTR) showed a weekly performance of 4.19%.
Twitter Inc (NYSE:TWTR) is to keep the 140-character limit for tweets, chief executive Jack Dorsey has announced.
On 08 April, Koninklijke Philips N.V (NYSE:PHG) shares increased 2.13% and was closed at $27.31. PHG EPS growth in last 5 year was -22.50%. Koninklijke Philips N.V (NYSE:PHG) year to date (YTD) performance is 7.31%.
Koninklijke Philips N.V (NYSE:PHG) has named six banks and filed draft documents for a possible initial public offering of its lighting division even as a process to sell the business through an auction continues.
Summit Midstream Partners, LP (NYSE:SMLP) shares increased 6.28% in last trading session and ended the day at $17.60. SMLP Gross Margin is 68.00% and its has a return on assets of -9.40%. Summit Midstream Partners, LP (NYSE:SMLP) quarterly performance is 2.22%.
Summit Midstream Partners LP (NASDAQ:SMLP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Analyst Ratings Net reports. The firm presently has a $18.00 price target on the stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.72% from the stock’s current price.
Viking Therapeutics, Inc. (NASDAQ:VKTX) caters to the Healthcare space. Its weekly performance is -17.12%. On the last day of trading company shares ended up at $1.21. Viking Therapeutics, Inc. (NASDAQ:VKTX) distance from 50-day simple moving average (SMA50) is 7.72%.
Viking Therapeutics, Inc. (NASDAQ:VKTX) announced the pricing of an underwritten public offering of 7,500,000 shares of its common stock and warrants to purchase up to 7,500,000 shares of its common stock at a public offering price of $1.25 per share of common stock and related warrant, for total expected gross proceeds to Viking of approximately $9,375,000, before deducting underwriting discounts, commissions, and other offering expenses
Leave a Reply